asimov.com

Avaliação do site asimov.com

Asimov — Intelligent Design

 Gerado a 30 de Março de 2026 15:19 PM

Estatísticas desatualizadas? ATUALIZE !

O resultado é de 56/100

Conteúdo SEO

Título

Asimov — Intelligent Design

Cumprimento : 27

Perfeito, o Título contém entre 10 e 70 caracteres.

Descrição

Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.

Cumprimento : 154

Perfeito, a Descrição META contém entre 70 e 160 caracteres.

Palavras-chave

Mau. Não detetámos palavras-chave META na sua página.

Propriedades Og Meta

Boa! Esta página tira vantagens das propriedades Og.

Propriedade Conteúdo
type website

Cabeçalhos

H1 H2 H3 H4 H5 H6
1 87 80 0 0 0
  • [H1] Intelligent designof living systems
  • [H2] Enabling the design and manufacture of advanced therapies
  • [H2] Our approach
  • [H2] How to work with us
  • [H2] Two ways to work with us
  • [H2] Built by genetic designers, for biotech builders
  • [H2] Supported by top investors and US research agencies
  • [H2] Partnered with over 25 companies, from small biotechs to big pharma
  • [H2] In the press
  • [H2] Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
  • [H2] Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
  • [H2] Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
  • [H2] Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
  • [H2] Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
  • [H2] Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
  • [H2] Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
  • [H2] Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
  • [H2] Optimizing Bispecific Antibody Expression with Amgen
  • [H2] Optimizing Bispecific Antibody Expression with Amgen
  • [H2] Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
  • [H2] Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
  • [H2] Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapy’s Path to Clinic
  • [H2] Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapy’s Path to Clinic
  • [H2] Asimov Enters into Agreement with BARDA's BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses
  • [H2] Asimov Enters into Agreement with BARDA's BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses
  • [H2] Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System
  • [H2] Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System
  • [H2] Cytiva and Asimov collaborate on next generation cell line design and process development
  • [H2] Cytiva and Asimov collaborate on next generation cell line design and process development
  • [H2] LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing
  • [H2] LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing
  • [H2] Novo Nordisk license CHO Edge System
  • [H2] Novo Nordisk license CHO Edge System
  • [H2] Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
  • [H2] Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
  • [H2] Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
  • [H2] Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
  • [H2] Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
  • [H2] Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
  • [H2] Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
  • [H2] Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
  • [H2] Asimov launches LV Edge Packaging System to optimize lentivirus production
  • [H2] Asimov launches LV Edge Packaging System to optimize lentivirus production
  • [H2] Announcing Asimov Press
  • [H2] Announcing Asimov Press
  • [H2] Asimov Labs
  • [H2] Asimov Labs
  • [H2] Lift Off
  • [H2] Lift Off
  • [H2] Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
  • [H2] Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
  • [H2] Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
  • [H2] Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
  • [H2] Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
  • [H2] Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
  • [H2] Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
  • [H2] Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
  • [H2] Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
  • [H2] Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
  • [H2] Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology
  • [H2] Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology
  • [H2] MIT Startup Exchange Names Asimov to STEX25
  • [H2] MIT Startup Exchange Names Asimov to STEX25
  • [H2] MIT Spinout Asimov Implements Programming Language for Cells
  • [H2] MIT Spinout Asimov Implements Programming Language for Cells
  • [H2] How Programmable DNA Strands Could Control Healing
  • [H2] How Programmable DNA Strands Could Control Healing
  • [H2] The automatic-design tools that are changing synthetic biology
  • [H2] The automatic-design tools that are changing synthetic biology
  • [H2] Biologists would love to program cells as if they were computer chips
  • [H2] Biologists would love to program cells as if they were computer chips
  • [H2] How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
  • [H2] How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
  • [H2] Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
  • [H2] Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
  • [H2] Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
  • [H2] Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
  • [H2] Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
  • [H2] Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
  • [H2] Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
  • [H2] Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
  • [H2] Asimov
  • [H2] Asimov
  • [H2] Cellular Circuit Computes with DNA
  • [H2] Cellular Circuit Computes with DNA
  • [H2] A programming language for living cells
  • [H2] A programming language for living cells
  • [H2] We're hiring at the intersection of biology, engineering, and machine learning.
  • [H3] Biologics
  • [H3] Cell Therapies
  • [H3] Gene Therapies
  • [H3] Host cells
  • [H3] Genetic parts library
  • [H3] Design software
  • [H3] Host cell lines
  • [H3] Genetic parts library
  • [H3] Design software
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We transfer our platform to your lab
  • [H3] We ship you host cells and grant software access
  • [H3] You design DNA
  • [H3] We ship DNA to you
  • [H3] You perform cell line development
  • [H3] We perform services in our lab
  • [H3] You request a stable cell line
  • [H3] We perform cell line and process development
  • [H3] We collaborate and share progress
  • [H3] We ship you clonal, stable cell lines
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We transfer our platform to your lab
  • [H3] We develop a cell line for you
  • [H3] We ship you host cells and grant software access
  • [H3] You design DNA
  • [H3] We ship DNA to you
  • [H3] You perform cell line development
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We perform services in our lab
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request a stable cell line
  • [H3] We perform cell line and process development
  • [H3] We collaborate and share progress
  • [H3] We ship you clonal, stable cell lines
  • [H3] Everything you need
  • [H3] From our lab to yours
  • [H3] We use our own platform every day

Imagens

Encontrámos 285 imagens nesta página.

214 atributos ALT estão vazios ou em falta. É recomendado adicionar texto alternativo de modo a que os motores de busca identifiquem melhor o conteúdo das suas imagens.

Rácio Texto/HTML

Rácio : 11%

O rácio de texto para código HTML desta página é menor que 15 porcento, o que significa que provavelmente é necessário de adicionar mais conteúdos em forma de texto.

Flash

Perfeito, não foi encontrado conteúdo Flash nesta página.

Iframe

Oh, não, esta página tem Iframes na página, o que significa que o conteúdo destas não pode ser indexado.

Reescrita de URL

Perfeito. As ligações aparentam ser limpas!

Underscores (traços inferiores) nas URLs

Perfeito. Não foram encontrados 'underscores' (traços inferiores) nas suas URLs.

Ligações para a própria página

Encontrámos um total de 4 ligações incluindo 0 ligações a ficheiros

Âncoras Tipo Sumo
Biologics Internas Passa sumo
Cell Therapies Internas Passa sumo
Gene Therapies Internas Passa sumo
Sign up Internas Passa sumo

Palavras-chave SEO

Núvem de palavras-chave

design development more cells blog cell line asimov software read

Consistência das Palavras-chave

Palavra-chave Conteúdo Título Palavras-chave Descrição Cabeçalhos
cell 113
more 86
asimov 85
read 79
line 79

Usabilidade

Url

Domínio : asimov.com

Cumprimento : 10

Favicon

Ótimo, o site tem um favicon.

Facilidade de Impressão

Não encontrámos CSS apropriado para impressão.

Língua

Otimo! A língua declarada deste site é en.

Dublin Core

Esta página não tira vantagens do Dublin Core.

Documento

Tipo de Documento

HTML 5

Codificação

Perfeito. O conjunto de caracteres UTF-8 está declarado.

Validação W3C

Erros : 0

Avisos : 0

Privacidade do Email

Aviso! No mínimo, foi encontrado um endereço de email sob a forma de texto. Isto é um convite para que spammers entupam a caixa de correio deste endereço.

HTML obsoleto

Fantástico! Não detetámos etiquetas HTML obsoletas.

Dicas de Velocidade

Excelente, este site não usa tablelas dentro de tabelas.
Oh não, o site usa estilos CSS nas etiquetas HTML.
Boa, o site usa poucos ficheiros CSS.
Oh, não! O site utiliza demasiados ficheiros JavaScript (mais que 6).
Perfeito, o site tira vantagens da compressão gzip.

Dispositivos Móveis

Otimização para dispositivos móveis

Icon Apple
Meta Viewport Tag
Conteúdo Flash

Otimização

XML Sitemap

Perfeito, o site tem um mapa XML do site (sitemap).

https://www.asimov.com/sitemap.xml

Robots.txt

https://asimov.com/robots.txt

Perfeito, o seu site tem um ficheiro robots.txt.

Analytics

Perfeito, o site tem uma ferramenta analítica para a análise de atividade.

   Google Analytics

PageSpeed Insights

Dispositivo
Categorias

Free SEO Testing Tool

Free SEO Testing Tool é uma ferramenta gratuita que o ajuda a avaliar o seu site